Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACROGENICS INC Director's Dealing 2023

Feb 24, 2023

34129_dirs_2023-02-24_8f19f4de-be76-44c7-8e1e-ef1a8ebc0cb2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2023-02-22

Reporting Person: Bonvini Ezio (Sr VP, Research & CSO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-02-22 Common Stock M 9375 Acquired 123799 Direct
2023-02-22 Common Stock F 3619 $6.55 Disposed 120180 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-02-22 Restricted Stock Unit $0.0 M 9375 Disposed Common Stock (9375.0) Direct

Footnotes

F1: On February 22, 2022 the reporting person was granted 37,500 restricted stock units, 25% of which vested on February 22, 2023 and 75% of which will vest two years after the date of grant. Restricted stock units convert into the Company's stock on a one-for-one basis.